F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure medications were obtained in a timely manner to
prevent residents from missing medication doses as ordered by the provider.
This applies to 1 of 3 residents (R1) reviewed for improper nursing care in the area of missing medication
doses in the sample of 4.
The findings include:
R1's EMR (Electronic Medical Record) showed R1 was admitted to the facility on [DATE], with multiple
diagnoses including lumbosacral spinal fusion, lumbar spine stenosis, anxiety, and breast cancer.
R1's MDS (Minimum Data Set) dated June 13, 2025, showed R1 was cognitively intact.
R1's Order Summary Report dated June 24, 2025, showed an order dated June 13, 2025, for Temazepam
capsule 7.5 mg (milligrams), give one capsule by mouth at bedtime for insomnia.
On June 23, 2025, at 2:46 PM, R1 said while she was residing at the facility, she was not able to sleep. R1
said she spoke with a provider and was told temazepam was ordered for her to sleep. R1 said she never
received a dose of temazepam.
R1's June 2025 MAR (Medication Administration Record) showed R1 did not receive temazepam as
ordered on June 13 and June 14, 2025.
A progress note dated June 13, 2025, at 10:17 PM, by V12 (RN/Registered Nurse) showed Temazepam
capsule 7.5 mg, give one capsule by mouth at bedtime for insomnia. Not available. Order on progress.
Physician and resident aware.
A progress note dated June 14, 2025, at 9:47 PM, by V12 showed Temazepam capsule 7.5 mg, give one
capsule by mouth at bedtime for insomnia. Not available. Order on progress. Physician aware.
On June 25, 2025, at 1:21 PM, V12 said on June 13, 2025, R1 had an order for temazepam, but since the
temazepam is a controlled substance, a script is required for pharmacy to fill the prescription. V12
continued to say V14 (Psychiatric Nurse Practitioner) is the provider who ordered the temazepam but V12
did not have a way to contact V14 regarding a script. V12 continued to say on June 13, V12 notified V17
(R1's Doctor) that a script was required in order for pharmacy to fill the temazepam order. V12 said she did
not receive a script from V17. V12 continued to say she did not notify a
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
145522
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145522
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/26/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Beacon Hill
2400 South Finley Road
Lombard, IL 60148
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
provider on June 14, 2025, when the temazepam was still unavailable.
Level of Harm - Minimal harm
or potential for actual harm
On June 25, 2025, at 12:11 PM, V11 (Pharmacy Account Manager) said temazepam is not listed on R1's
medication profile for the pharmacy. V11 said since the temazepam is not on R1's profile it means the
pharmacy did not receive a script for the medication.
Residents Affected - Few
On June 25, 2025, at 1:56 PM, V1 (Administrator) said it should not have taken over 24 hours for R1's
temazepam to be available to be administered.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145522
If continuation sheet
Page 2 of 2